ALTRATECH LIMITED R&D FOR DESIGN, SYNTHESIZE AND VERIFY PROPRIETARY PNA PROBES FOR SEQUENCE SPECIFIC CAPTURE OF SARS-COV-2 RNA DIRECTLY FROM A BIOLOGICAL SAMPLE. AOI #11B: ENABLING TECHNOLOGIES TO SUPPORT HOME-BASED DIAGNOSTICS FOR SARS-COV-2 A

  • Funded by Biomedical Advanced Research and Development Authority (BARDA)
  • Total publications:0 publications

Grant number: 75A50122C00067

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2022
    2024
  • Known Financial Commitments (USD)

    $309,084.78
  • Funder

    Biomedical Advanced Research and Development Authority (BARDA)
  • Research Location

    Ireland
  • Lead Research Institution

    ALTRATECH LIMITED
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics
  • Research Subcategory

    Diagnostics
  • Special Interest Tags

    N/A
  • Study Type

    Non-Clinical
  • Clinical Trial Details

    N/A
  • Broad Policy Alignment

    Pending
  • Age Group

    Not Applicable
  • Vulnerable Population

    Not applicable
  • Occupations of Interest

    Not applicable

Abstract

ALTRATECH LIMITED R&D FOR DESIGN, SYNTHESIZE AND VERIFY PROPRIETARY PNA PROBES FOR SEQUENCE SPECIFIC CAPTURE OF SARS-COV-2 RNA DIRECTLY FROM A BIOLOGICAL SAMPLE. AOI #11B: ENABLING TECHNOLOGIES TO SUPPORT HOME-BASED DIAGNOSTICS FOR SARS-COV-2 A